McKesson EBIT 2012-2026 | MCK
McKesson annual and quarterly EBIT history from 2012 to 2026. EBIT can be defined as earnings before interest and taxes.
- McKesson EBIT for the quarter ending March 31, 2026 was $2.150B, a 35.14% increase year-over-year.
- McKesson EBIT for the twelve months ending March 31, 2026 was $6.212B, a 40.48% increase year-over-year.
- McKesson 2026 annual EBIT was $6.212B, a 40.48% increase from 2025.
- McKesson 2025 annual EBIT was $4.422B, a 13.12% increase from 2024.
- McKesson 2024 annual EBIT was $3.909B, a 10.77% decline from 2023.
|
McKesson Annual EBIT (Millions of US $) |
|
|---|---|
| 2026 | $6,212 |
| 2025 | $4,422 |
| 2024 | $3,909 |
| 2023 | $4,381 |
| 2022 | $2,038 |
| 2021 | $-5,040 |
| 2020 | $2,489 |
| 2019 | $886 |
| 2018 | $762 |
| 2017 | $7,122 |
| 2016 | $3,545 |
| 2015 | $2,968 |
| 2014 | $2,439 |
| 2013 | $2,347 |
| 2012 | $2,124 |
|
McKesson Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2026-03-31 | $2,150 |
| 2025-12-31 | $1,619 |
| 2025-09-30 | $1,407 |
| 2025-06-30 | $1,036 |
| 2025-03-31 | $1,591 |
| 2024-12-31 | $1,224 |
| 2024-09-30 | $578 |
| 2024-06-30 | $1,029 |
| 2024-03-31 | $1,216 |
| 2023-12-31 | $642 |
| 2023-09-30 | $951 |
| 2023-06-30 | $1,100 |
| 2023-03-31 | $980 |
| 2022-12-31 | $1,241 |
| 2022-09-30 | $1,124 |
| 2022-06-30 | $1,036 |
| 2022-03-31 | $633 |
| 2021-12-31 | $298 |
| 2021-09-30 | $539 |
| 2021-06-30 | $568 |
| 2021-03-31 | $1,010 |
| 2020-12-31 | $-7,362 |
| 2020-09-30 | $634 |
| 2020-06-30 | $678 |
| 2020-03-31 | $869 |
| 2019-12-31 | $360 |
| 2019-09-30 | $626 |
| 2019-06-30 | $634 |
| 2019-03-31 | $-569 |
| 2018-12-31 | $683 |
| 2018-09-30 | $689 |
| 2018-06-30 | $83 |
| 2018-03-31 | $-944 |
| 2017-12-31 | $834 |
| 2017-09-30 | $239 |
| 2017-06-30 | $633 |
| 2017-03-31 | $4,739 |
| 2016-12-31 | $831 |
| 2016-09-30 | $580 |
| 2016-06-30 | $972 |
| 2016-03-31 | $740 |
| 2015-12-31 | $920 |
| 2015-09-30 | $954 |
| 2015-06-30 | $931 |
| 2015-03-31 | $700 |
| 2014-12-31 | $800 |
| 2014-09-30 | $787 |
| 2014-06-30 | $681 |
| 2014-03-31 | $605 |
| 2013-12-31 | $493 |
| 2013-09-30 | $686 |
| 2013-06-30 | $655 |
| 2013-03-31 | $667 |
| 2012-12-31 | $498 |
| 2012-09-30 | $606 |
| 2012-06-30 | $576 |
| 2012-03-31 | $682 |
| 2011-12-31 | $492 |
| 2011-09-30 | $478 |
| 2011-06-30 | $472 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $106.025B | $359.051B |
| McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |